相关实验视频
Updated: Jul 11, 2025

07:32
Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
4.1K
肠道微生物组补充作为代谢综合征治疗的疗法
Mc Anto Antony1, Aniqa Chowdhury2, Dinesh Edem3
1Department of Endocrinology, Diabetes and Metabolism, Medical University of South Carolina/AnMed Campus, Anderson, SC 29621, United States. drmcanto@gmail.com.
World journal of diabetes
|November 16, 2023
概括
肠道微生物群影响代谢综合征. 像益生菌和益生菌这样的补充剂可以恢复肠道健康,减少受影响个体的炎症和胰岛素抵抗.
科学领域:
- 微生物学 微生物学
- 代谢健康 代谢健康
- 营养科学 营养科学
背景情况:
- 肠道微生物组失调与慢性炎症,胰岛素抵抗,心血管疾病 (CVD),2型糖尿病 (T2DM) 和肥胖有关.
- 代谢综合征,以肥胖,高血糖和脂质失调为特征,增加了心血管疾病和T2DM的风险.
- 肠道微生物组越来越被认为是代谢综合征的关键调节器.
研究的目的:
- 审查对调节肠道微生物群的补充剂的当前研究.
- 探索益生菌,益生菌,共生菌和后生菌对肠道微生物群组成的影响.
- 通过减少炎症和胰岛素抵抗来评估这些补充剂在治疗代谢综合征方面的潜力.
主要方法:
- 关于肠道微生物组和代谢综合征的当前研究的文献综述.
- 对研究研究益生菌,益生菌,共生菌和后生菌的影响的分析.
- 综合有关有益和有害肠道微生物群的调节的发现.
主要成果:
- 肠道微生物组失调与代谢综合征的组成部分有关.
- 补充剂可以影响有益的肠道细菌的丰富性.
- 益生菌,益生菌,共生菌和后生菌显示出改善肠道健康和代谢参数的潜力.
结论:
- 肠道微生物组在代谢综合征中起着重要作用.
- 用补充剂向肠道微生物群提供了一个有希望的治疗策略.
- 需要进一步的研究来优化基于补充剂的干预措施,以治疗代谢综合征.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
337
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
337
What is Monogastric Digestion?
71.2K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.2K
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Irritable Bowel Syndrome I: Introduction
280
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
Drugs for Treatment of Constipation-Predominant IBS
180
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
180
Fungal Phylum Microsporidia
19
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
19

